HomeQuestion
When would you consider neoadjuvant immunotherapy for advanced melanoma?
1 Answers
Mednet Member
Medical Oncology · University of Pittsburgh School of Medicine
Neoadjuvant immunotherapy is a reasonable if investigational approach to melanoma. The role of neoadjuvant therapy as an investigative approach lies in its ability to give both efficacy information and Biomarker information. We have published encouraging results with interferons 12 years ago, (Mosch...